Digital CBT Outperforms Psychoeducation in Generalized Anxiety Disorder
Participants receiving digital cognitive behavioral therapy had higher remission rates and lower anxiety severity than those assigned to psychoeducation
A randomized clinical trial of adults with generalized anxiety disorder (GAD) evaluated a smartphone-delivered digital cognitive behavioral therapy (DCBT) program against an active psychoeducation control. The study involved 351 adults with severe GAD symptoms, demonstrating that DCBT led to significant and sustained improvements over 24 weeks. Key findings included higher remission rates in the DCBT group (71.0% at 10 weeks, 77.7% at 24 weeks) compared to the control group (34.6% and 52.0%, respectively). Secondary benefits were noted in depressive symptoms and sleep quality, indicating DCBT as a scalable option to improve access to effective GAD treatments.
1. Trial involved 351 adults with GAD. 2. DCBT led to 71.0% remission at 10 weeks. 3. At 24 weeks, remission increased to 77.7%. 4. DCBT also improved depressive symptoms and sleep quality. 5. Design features included independent evaluators and high retention. 6. Adverse events were infrequent. 7. Effective for accessing psychotherapy in challenging settings. 8. No replacement for traditional therapy, but a scalable adjunctive option.